Artículos por temáticas

How psychogenic" are psychogenic movement disorders?"

Stone J, Edwards MJ.

Mov Disord. 2011 Aug 15;26(10):1787-8. doi: 10.1002/mds.23882. No abstract available.

Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.

Merello M, Gerschcovich ER, Ballesteros D, Cerquetti D.

Parkinsonism Relat Disord. 2011 Nov;17(9):705-7. doi: 10.1016/j.parkreldis.2011.07.002.

Translational research in neurology and neuroscience 2011: movement disorders.

Klein C, Krainc D, Schlossmacher MG, Lang AE.

Arch Neurol. 2011 Jun;68(6):709-16. doi: 10.1001/archneurol.2011.11. Review.

A film of patients with movement disorders made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson.

Reynolds EH, Healy DG, Lees AJ.

Mov Disord. 2011 Dec;26(14):2453-9. doi: 10.1002/mds.23536.

The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.

Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O.

Mov Disord. 2011 Sep;26(11):1985-92. doi: 10.1002/mds.23742. Review.

An update on psychogenic movement disorders.

Ellenstein A, Kranick SM, Hallett M.

Curr Neurol Neurosci Rep. 2011 Aug;11(4):396-403. doi: 10.1007/s11910-011-0205-z. Review.

Guidelines for the use of botulinum toxin in movement disorders and spasticity.

Jabeen A, Kandadai RM, Kannikannan MA, Borgohain R.

Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S31-4. doi: 10.4103/0972-2327.83099. No abstract available.

Sleep-related movement disorders.

Freedom T.

Dis Mon. 2011 Aug;57(8):438-47. doi: 10.1016/j.disamonth.2011.06.006. Review. No abstract available.

Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis.

Koning JP, Tenback DE, Kahn RS, Vollema MG, Cahn W, van Harten PN.

Psychol Med. 2011 Oct;41(10):2141-7. doi: 10.1017/S0033291711000389.

Movement disorders: Cerebellum and basal ganglia interaction essential in RDP.

Ray K.

Nat Rev Neurol. 2011 Apr;7(4):188. doi: 10.1038/nrneurol.2011.35. No abstract available.

[Cyclic episodes of confusion and movement disorders: consider hyopglycemia and insulinoma].

Verschoor CJ, Oranje WA, Maas HA.

Tijdschr Gerontol Geriatr. 2011 Apr;42(2):96-100. Dutch.

Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients.

Franzini A, Cordella R, Messina G, Marras CE, Romito LM, Carella F, Albanese A, Rizzi M, Nardocci N, Zorzi G, Zekay E, Broggi G.

J Neural Transm (Vienna). 2011 Oct;118(10):1497-510. doi: 10.1007/s00702-011-0656-z.

Movement disorders in spinocerebellar ataxias.

Pedroso JL, Felicio AC, Braga-Neto P, Barsottini OG.

Mov Disord. 2011 Oct;26(12):2302. doi: 10.1002/mds.23928. No abstract available.

Sleep-to-wake transition movement disorders.

Vetrugno R, Montagna P.

Sleep Med. 2011 Dec;12 Suppl 2:S11-6. doi: 10.1016/j.sleep.2011.10.005. Review.

[Movement disorders and neurometabolic diseases].

Grabli D, Auré K, Roze E.

Rev Neurol (Paris). 2011 Feb;167(2):123-34. doi: 10.1016/j.neurol.2010.07.022. Review. French.